BridgeBio Pharma Inc (BBIO)

BridgeBio Pharma (BBIO) Cash flow


BridgeBio Pharma Cash Flow

BBIO's free cash flow for Q4 2023 was $-125.25M. For the 2023 fiscal year, BBIO's free cash flow was decreased by $-113.21M and operating cash flow was $-124.82M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -527.72M$ -527.72M$ -419.49M$ -497.98M$ -399.71M$ -253.59M
Investing Cash Flow
$ 54.03M$ 54.03M$ 453.15M$ -200.83M$ -52.99M$ -217.25M
Financing Cash Flow
$ 451.54M$ 451.54M$ -13.13M$ 736.45M$ 447.19M$ 398.79M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 1.68B$ 394.73M$ 416.88M$ 396.31M$ 358.68M$ 364.20M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
$ 61.11M$ 61.11M$ 54.44M$ 29.77M$ 15.32M$ 6.09M
Issuance Of Capital Stock
$ 388.24M$ 388.24M$ 7.41M$ 3.82M$ 0.00$ 366.24M
Issuance Of Debt
--$ -20.49M$ 1.08B$ 550.00M$ 37.12M
Repayment Of Debt
--$ -20.49M$ -124.12M$ 0.00$ 0.00
Free Cash Flow
$ -383.37M$ -529.03M$ -415.81M$ -546.23M$ -407.23M$ -258.73M
Domestic Sales
Foreign Sales
Currency in USD

BridgeBio Pharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis